Consecutive Commodities Rights Issue 2026: Key Dates

What the company is doing and why it matters

Consecutive Commodities Limited has launched a rights issue to raise up to ₹48.05 crore by issuing 48,04,50,000 fully paid-up equity shares. The issue price is ₹1 per share, which is also the face value, meaning the issue is at par. The offer is made to eligible equity shareholders in a 3:1 ratio, based on holdings as of the record date.

For shareholders, the key operational takeaway is the timeline. The company has extended the rights issue closing date, which changes the last day to act if an investor plans to apply for shares or renounce (sell) rights entitlements (REs). The rights issue is expected to result in listing of the allotted rights shares on BSE after allotment.

Rights issue size, price, and entitlement ratio

The Letter of Offer covers 48,04,50,000 equity shares at ₹1 each, aggregating to ₹48.05 crore. The entitlement ratio is 3 rights equity shares for every 1 equity share held as on the record date. Application money is payable in full at the time of application, and the company has stated that proceeds will be used primarily for working capital and general corporate purposes.

One dataset also describes the issuer as Consecutive Investment & Trading Company Ltd, while other parts consistently refer to Consecutive Commodities Limited, including the BSE scrip code reference (539091) and the RE symbol. Investors typically rely on the Letter of Offer and exchange filings for the final, operative terms.

Record date and last date to buy shares

The rights issue record date is stated as June 8, 2026. The last date to buy shares to be eligible for REs is mentioned as June 5, 2026, aligning with the ex-rights date/record date mechanics.

This matters because only shareholders on record as of the record date receive REs in their demat accounts. If an investor buys after the last eligible date, they generally will not receive the REs for this issue.

Issue schedule and the revised closing date

The issue opening date is stated as July 2, 2026, and the initial closing date is stated as July 24, 2026, with BSE Limited as the designated stock exchange. Separately, the company later extended the rights issue closing date to July 31, 2026, following committee approval dated July 17, 2026.

Alongside the extension, the renunciation trading period was also revised. The updated information states that the renunciation trading period would close on July 27, 2026, and the last date for CAF submission is July 31, 2026.

The article text also contains earlier schedule references, including a board revision that set the issue opening date as June 29, 2026 (instead of June 24, 2026) with the closing date July 24, 2026, and another public-announcement-style timeline that mentioned June 18, 2026 to July 7, 2026. These multiple versions indicate that the schedule was revised more than once.

Rights Entitlements (REs): trading, symbol, and extinction

Rights Entitlements (REs) are credited to eligible shareholders prior to the issue opening date under a stated ISIN: INE187R20011. The RE symbol is mentioned as CCDL-RE. REs can typically be used in two ways: apply for rights shares, or renounce by selling the REs on the stock exchange during the trading window.

The text notes that REs are temporarily traded on the exchanges and then extinguished. It also mentions a RE trading period of July 2, 2026 to July 20, 2026 in one section, while the extension note indicates the renunciation trading now closes on July 27, 2026.

Use of proceeds and issue expenses

The company has disclosed a use-of-funds split from net proceeds. Total proceeds are stated as ₹48.05 crore, with ₹0.25 crore mentioned as rights issue process expenses. The net proceeds are stated as ₹47.80 crore.

From the net proceeds, the company has stated it will use ₹37.44 crore for working capital and ₹10.36 crore for general corporate purposes. These figures are explicitly stated in the provided text and sum to the stated net proceeds.

Capital impact after the rights issue

The article text states that, post allotment, the company’s paid-up equity capital is expected to increase from ₹16.01 crore to ₹64.06 crore. This is a key structural detail for investors assessing dilution, expanded equity base, and potential post-issue share supply.

While this increase reflects the expanded capital base after issuing the new shares, investors typically compare it with business performance and disclosures in the offer document.

How shareholders can apply: ASBA and offline routes

The text lists multiple application routes. Investors can apply online via netbanking ASBA (Applications Supported by Blocked Amount) if their bank supports it. Another method mentioned is the R-WAP facility provided by the registrar (where applicable). For those without online ASBA access, an offline or physical ASBA route is described via submission at a Self-Certified Syndicate Bank (SCSB) branch.

Applicants will need to enter their demat Beneficiary Owner ID (16-digit). The full issue price of ₹1 per share is payable at the time of application.

Key terms at a glance

Timeline changes mentioned across disclosures

Market impact and what investors should track

A rights issue at ₹1 per share can attract attention because it is priced at par and significantly increases the equity base, as reflected in the paid-up capital rise from ₹16.01 crore to ₹64.06 crore stated in the text. The direct implication for shareholders is the choice between subscribing (to maintain ownership proportion) or selling REs during the renunciation window.

Operationally, the most important investor action points are the record date eligibility (June 8, 2026), the last date to buy shares (June 5, 2026), and the revised closing date (July 31, 2026) mentioned in the extension update. Investors also need to track the final RE trading/renunciation end date cited, given the text includes both July 20 and the revised July 27.

Conclusion

Consecutive Commodities Limited’s rights issue is structured as a 3:1 offer at ₹1 per share to eligible shareholders as of June 8, 2026, aiming to raise ₹48.05 crore. The company has extended the issue closing date to July 31, 2026, and updated the renunciation and CAF submission timelines. Investors typically align their decision-making with the final exchange notices and the company’s Letter of Offer, especially when multiple schedule revisions are referenced.